Harvard study links prenatal Tylenol use to autism, ADHD risk

A Harvard-led analysis of 46 studies worldwide has found evidence linking prenatal acetaminophen use to higher risks of autism and attention-deficit/hyperactivity disorder in children. The research, published in BMC Environmental Health, represents one of the most comprehensive reviews to date of a question that has shadowed pregnancy care for decades: whether this common painkiller and fever reducer, taken by millions of pregnant people, might affect fetal brain development.

Andrea Baccarelli, dean of the faculty at Harvard T.H. Chan School of Public Health and a professor of environmental health, led the senior authorship of the study alongside researchers from the Icahn School of Medicine at Mount Sinai, UCLA, the University of Massachusetts Lowell, and other institutions. The team employed the Navigation Guide Systematic Review methodology, a rigorous framework designed specifically for synthesizing environmental health evidence. They examined decades of global research investigating whether acetaminophen exposure during pregnancy correlated with neurodevelopmental disorders—the clinical term for conditions like autism and ADHD that affect how the brain develops and functions.

The findings carry weight precisely because they are not absolute. The researchers found what they describe as an association, not proof of causation. The link appears strongest when acetaminophen is used continuously for four weeks or longer during pregnancy. Baccarelli noted in his statement that "further research is needed to confirm the association and determine causality," a careful distinction that matters enormously in medicine. An association means two things occur together more often than chance would predict; causality means one directly causes the other. The difference shapes how doctors and patients should respond.

That response, according to the researchers, should not be a blanket prohibition. Acetaminophen remains important for managing pain and fever during pregnancy, both of which carry their own risks to fetal development. High fever during pregnancy can increase the likelihood of neural tube defects and preterm birth. The researchers recommend instead what they call judicious use: the lowest effective dose, taken for the shortest necessary duration, always under medical guidance tailored to each person's individual circumstances. This is a more nuanced position than a simple warning—it acknowledges that the drug serves a purpose while urging caution about how it is used.

In late September, the Food and Drug Administration announced it would send a letter to clinicians urging caution about acetaminophen use in pregnancy, a move that appears to have been informed by this research. Baccarelli disclosed that he had discussed his findings with Robert F. Kennedy Jr., the Secretary of Health and Human Services, in the weeks before the FDA announcement and provided the White House with a statement summarizing his work. The timing and the disclosure raise questions about the relationship between academic research, regulatory action, and political influence—questions that Baccarelli himself acknowledged by noting in the study's competing interests section that he has served as an expert witness for plaintiffs in litigation involving acetaminophen and neurodevelopmental disorders.

The research was funded by the National Cancer Institute, the National Institute of Environmental Health Sciences, and the National Institute on Aging, suggesting this question sits at the intersection of multiple public health concerns. What remains unclear is whether the association the researchers identified reflects a genuine causal mechanism—perhaps acetaminophen interfering with fetal brain development—or whether it reflects other factors. Pregnant people who use acetaminophen might differ in other ways from those who do not, and those differences might themselves affect neurodevelopmental risk. The next phase of research will need to untangle these possibilities. For now, the message to pregnant people and their doctors is clear: use acetaminophen if you need it, but use it thoughtfully, with full awareness of what is known and what remains to be learned.